Franklin Genomic Advancements ETF HELX CBOE · Financials · United States
$42.51 +0.00% +$0.00
Summary
Franklin Genomic Advancements ETF is an ETF - a fund traded on an exchange like a stock - run by Franklin Templeton. Positions inside: 70. The ten largest make up 47% of the fund.
- Yearly costs
- 0.50%
- Fund size
- $34.0M
- Positions
- 70
- Dividend yield
- 0.34%
- Running since
- 2020
What speaks for it
Nothing stands out in its favour.
What to watch
- 97% of the fund is in one sector (Healthcare).
- 95% of the fund is in one country (United States).
- Costs of 0.50% a year are above the middle of comparable funds (0.45%).
- In the last five years its price once dropped by 59% from its high.
- A small fund with $34.0M under management; small funds get closed more often.
- It trades little: only about $220.0K changes hands a day.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- +3.4%
- 3 months
- +5.0%
- This year
- +17%
- 1 year
- +22%
- 3 years
- +57%
- 5 years
- -17%
- Avg. market cap
- $69.1B
- P/E
- -
- Forward P/E
- -
- P/S
- 10.2x
- P/B
- 6.7x
- P/FCF
- 37.7x
- EV/EBITDA
- 29.3x
- Dividend yield
- 0.06%
- ROIC
- -9.4%
- ROE
- 7.3%
- Gross margin
- 67.2%
- Operating margin
- -40.6%
- Net margin
- -36.7%
- Payout ratio
- -
- Net debt/EBITDA
- 1.2x
- Beta
- 0.98
Weighted average of the 50 largest companies, which make up 95% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Moderately concentrated- 1 GHGuardant Health GH 8.6%
- 2 NTNatera NTRA 8.2%
- 3 ADAdaptive Biotechnologies Corporation ADPT 5.1%
- 4 KRKrystal Biotech KRYS 4.9%
- 5 LGLigand Pharmaceuticals LGND 4.6%
- 6 BBBridgeBio Pharma BBIO 3.5%
- 7 TWTwist Bioscience TWST 3.2%
- 8 LLEli Lilly LLY 2.9%
- 9 MEMedpace MEDP 2.9%
- 10 UTUnited Therapeutics UTHR 2.8%
Positions in the fund: 70. The ten largest make up 47% of it.
Composition as of Nov 14, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 97%
- Financials 2.2%
- Technology 0.7%
- Basic materials 0.3%
By country
- United States 95%
- South Korea 1.1%
- United Kingdom 1.1%
- Germany 1.0%
- Other countries 1.6%
By company size
- Mega cap 3.9%
- Large cap 57%
- Mid cap 35%
- Small cap 4.3%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.
Largest sector: Healthcare (97%). Largest country: United States (95%). Largest size group: Large cap (57%).
What does it cost me?
Expensive- A year from $10,000
- $50.00
- Over 20 years
- $2,416
From every $10,000 invested the fund takes $50.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,416.
How has it done?
Losing value- A year on average, 5 years
- -3.6%
- Deepest drop
- -59%
- Yearly volatility
- 26%
Average yearly decline over the last five years: 3.6%. Deepest drop in these years: 59% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 0.34%
- Payments a year
- 1
- Last payment
- $0.14
Over the last 12 months it paid $0.14 per share, which is 0.34% of today's price. The last payment was $0.14 on Dec 30, 2025.
Is it easy to buy and sell?
It trades little- Traded a day
- $220.0K
- Shares a day
- 5.2K
On an average day about $220.0K of the fund changes hands.
How expensive are the companies inside?
Rather expensive- Average Bulios Score
- 48 out of 100
Weight by Bulios Fair Price
- Undervalued 17%
- Fairly valued 6.7%
- Overvalued 76%
By Fair Price, 76% of the rated weight comes out as overvalued.
Counted from its largest companies (50), which make up 95% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Similar funds
Funds that hold much of the same. The overlap says how much of their weight they share with this fund.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
WD WDNA WisdomTree BioRevolution Fund | United States | 0.45% | $2.93M | +37% | Pays out | 31% |
XM XMLH.DE L&G Healthcare Technology & Innovation UCITS ETF | Ireland | 0.49% | $279.2M | +40% | Reinvests | 29% |
HT HTEC Robo Global Healthcare Technology and Innovation ETF | United States | 0.80% | $68.5M | +32% | Pays out | 28% |
GN GNOM Global X - Genomics & Biotechnology ETF | United States | 0.50% | $102.7M | +43% | Pays out | 28% |
IB IBB iShares Biotechnology ETF | United States | 0.44% | $11.0B | +29% | Pays out | 27% |
XB XBI SPDR S&P Biotech ETF | United States | 0.35% | $7.87B | +32% | Pays out | 26% |